The aim of this study was to investigate the protective effect of metformin against experimentally-induced prostatic hyperplasia in rats with emphasis on its potential effects on certain key players of IGF-1/IGF-1R signaling pathway. Here, IGF1R is linked to benign prostatic hyperplasia.